Investment Rating - The report maintains a "Buy" rating for the company [2] Core Insights - The company is transitioning from a high-end offline maternity service provider to a comprehensive maternal and infant health service platform driven by AI technology [4][5] - The "Bela Doctor" app serves as the core entry point for a full-cycle service ecosystem, integrating external AI capabilities and internal professional service systems [6] - The company has established a scientific "age-based parenting" service system, enhancing customer experience and brand loyalty [7] - Strategic investment in AI service provider WITH1000 AI aims to improve user understanding and industry standards [8] - Collaboration with China Merchants Bank to create a secure maternity guarantee fund account enhances customer confidence [9] Financial Projections - Revenue forecasts for 2025-2027 are projected at 1.076 billion, 1.403 billion, and 1.777 billion yuan, representing year-on-year growth of 34.73%, 30.42%, and 26.65% respectively [11] - Net profit forecasts for the same period are 315 million, 406 million, and 478 million yuan, with growth rates of 157.65%, 28.75%, and 17.71% respectively [11] - The company is expected to achieve an EPS of 0.51, 0.65, and 0.77 yuan for 2025, 2026, and 2027 [13]
圣贝拉（2508.HK）：以AI+服务为核心，全面升级母婴护理生态